glp 1 headache side effect GLP-1 medication effects for diabetes and weight loss GI Adverse Effects of Glucagon-Like

Featuring 4 patented ingredients clinically-studied to support natural GLP-1 production, satiety, fat metabolism and stable energy.

Noom issued a call for public support of a new petition demanding affordable choices and fair pricing for GLP-1 weight-loss medications

Johnson et al

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

We sought to investigate the real-world impact of sodiumglucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in individuals with type 1 diabetes in relation to effect on blood glucose levels, adverse events and cardio-renal outcomes